Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term 80 and over Aged. Found 139 abstracts

no pagination
Barr PM, Miller TP, Friedberg JW, Peterson DR, Baran AM, Herr M, Spier CM, Cui H, Roe DJ, Persky DO, Casulo C, Littleton J, Schwartz M, Puvvada S, Landowski TH, Rimsza LM, Dorr RT, Fisher RI, Bernstein SH, Briehl MM. Phase 2 study of imexon, a prooxidant molecule, in relapsed and refractory B-cell non-Hodgkin lymphoma. Blood. 2014 Aug 21;124(8):1259-65.   PMCID: Pmc4141515
Brana I, Berger R, Golan T, Haluska P, Edenfield J, Fiorica J, Stephenson J, Martin LP, Westin S, Hanjani P, Jones MB, Almhanna K, Wenham RM, Sullivan DM, Dalton WS, Gunchenko A, Cheng JD, Siu LL, Gray JE. A parallel-arm phase I trial of the humanised anti-IGF-1R antibody dalotuzumab in combination with the AKT inhibitor MK-2206, the mTOR inhibitor ridaforolimus, or the NOTCH inhibitor MK-0752, in patients with advanced solid tumours. Br J Cancer. 2014 Nov 11;111(10):1932-44.   PMCID: Pmc4229637
Burger RA, Brady MF, Bookman MA, Monk BJ, Walker JL, Homesley HD, Fowler J, Greer BE, Boente M, Fleming GF, Lim PC, Rubin SC, Katsumata N, Liang SX. Risk factors for GI adverse events in a phase III randomized trial of bevacizumab in first-line therapy of advanced ovarian cancer: A Gynecologic Oncology Group Study. J Clin Oncol. 2014 Apr 20;32(12):1210-7.   PMCID: Pmc3986384
Hurwitz MD, Ghanouni P, Kanaev SV, Iozeffi D, Gianfelice D, Fennessy FM, Kuten A, Meyer JE, LeBlang SD, Roberts A, Choi J, Larner JM, Napoli A, Turkevich VG, Inbar Y, Tempany CM, Pfeffer RM. Magnetic resonance-guided focused ultrasound for patients with painful bone metastases: phase III trial results. J Natl Cancer Inst. 2014 May;106(5).   PMCID: Pmc4112926
Johnson ME, Zhu F, Li T, Wu H, Galloway TJ, Farma JM, Perlis CS, Turaka A. Absolute lymphocyte count: a potential prognostic factor for Merkel cell carcinoma. J Am Acad Dermatol. 2014 Jun;70(6):1028-35.   PMCID: No NIH funding
Lango MN, Egleston B, Fang C, Burtness B, Galloway T, Liu J, Mehra R, Ebersole B, Moran K, Ridge JA. Baseline health perceptions, dysphagia, and survival in patients with head and neck cancer. Cancer. 2014 Mar 15;120(6):840-7.   PMCID: Pmc3951722
Martin JM, Handorf EA, Kutikov A, Uzzo RG, Bekelman JE, Horwitz EM, Smaldone MC. The rise and fall of prostate brachytherapy: use of brachytherapy for the treatment of localized prostate cancer in the National Cancer Data Base. Cancer. 2014 Jul 15;120(14):2114-21.
Martin LP, Sill M, Shahin MS, Powell M, DiSilvestro P, Landrum LM, Gaillard SL, Goodheart MJ, Hoffman J, Schilder RJ. A phase II evaluation of AMG 102 (rilotumumab) in the treatment of persistent or recurrent epithelial ovarian, fallopian tube or primary peritoneal carcinoma: a Gynecologic Oncology Group study. Gynecol Oncol. 2014 Mar;132(3):526-30.
Pisansky TM, Pugh SL, Greenberg RE, Pervez N, Reed DR, Rosenthal SA, Mowat RB, Raben A, Buyyounouski MK, Kachnic LA, Bruner DW. Tadalafil for prevention of erectile dysfunction after radiotherapy for prostate cancer: the Radiation Therapy Oncology Group [0831] randomized clinical trial. JAMA. 2014 Apr 02;311(13):1300-7.
Raman JD, Lin YK, Kaag M, Atkinson T, Crispen P, Wille M, Smith N, Hockenberry M, Guzzo T, Peyronnet B, Bensalah K, Simhan J, Kutikov A, Cha E, Herman M, Scherr D, Shariat SF, Boorjian SA. High rates of advanced disease, complications, and decline of renal function after radical nephroureterectomy. Urol Oncol. 2014 Jan;32(1):47e9-14.
Singla S, Papavasiliou P, Powers B, Gaughan J, von Mehren M, Watson JC, Farma JM. Challenges in the treatment of angiosarcoma: a single institution experience. Am J Surg. 2014 Aug;208(2):254-9.
Arrangoiz R, Papavasiliou P, Singla S, Siripurapu V, Li T, Watson JC, Hoffman JP, Farma JM. Partial stomach-partitioning gastrojejunostomy and the success of this procedure in terms of palliation. Am J Surg. 2013 Sep;206(3):333-9.   PMCID: No NIH funding
Meyer JE, Panico VJ, Marconato HM, Sherr DL, Christos P, Pirog EC. HIV positivity but not HPV/p16 status is associated with higher recurrence rate in anal cancer. J Gastrointest Cancer. 2013 Dec;44(4):450-5.   PMCID: Pmc3963822
Schilder RJ, Sill MW, Lankes HA, Gold MA, Mannel RS, Modesitt SC, Hanjani P, Bonebrake AJ, Sood AK, Godwin AK, Hu W, Alpaugh RK. A phase II evaluation of motesanib (AMG 706) in the treatment of persistent or recurrent ovarian, fallopian tube and primary peritoneal carcinomas: a Gynecologic Oncology Group study. Gynecol Oncol. 2013 Apr;129(1):86-91.   PMCID: PMC 3712785
Siddiqui AA, Chaaya A, Shelton C, Marmion J, Kowalski TE, Loren DE, Heller SJ, Haluszka O, Adler DG, Tokar JL. Utility of the short double-balloon enteroscope to perform pancreaticobiliary interventions in patients with surgically altered anatomy in a US multicenter study. Dig Dis Sci. 2013 Mar;58(3):858-64.   PMCID: No NIH funding
Stump TK, Eghan N, Egleston BL, Hamilton O, Pirollo M, Schwartz JS, Armstrong K, Beck JR, Meropol NJ, Wong YN. Cost concerns of patients with cancer. Journal of oncology practice / American Society of Clinical Oncology. 2013 Sep;9(5):251-7.   PMCID: Pmc3770507
Gumbs AA, Tsai TJ, Hoffman JP. Initial experience with laparoscopic hepatic resection at a comprehensive cancer center. Surg Endosc. 2012 Feb;26(2):480-7.   PMCID: not NIH funded
Hudson SV, Miller SM, Hemler J, Ferrante JM, Lyle J, Oeffinger KC, Dipaola RS. Adult cancer survivors discuss follow-up in primary care: 'not what i want, but maybe what i need'. Ann Fam Med. 2012 Sep;10(5):418-27.   PMCID: Pmc3438209
Kluhsman BC, Lengerich EJ, Fleisher L, Paskett ED, Miller-Halegoua SM, Balshem A, Bencivenga MM, Spleen AM, Schreiber P, Dignan MB. A pilot study for using fecal immunochemical testing to increase colorectal cancer screening in Appalachia, 2008-2009. Prev Chronic Dis. 2012 Jan;9:E77.   PMCID: Pmc3392085
Smaldone MC, Egleston B, Uzzo RG, Kutikov A. Does partial nephrectomy result in a durable overall survival benefit in the Medicare population?. J Urol. 2012 Dec;188(6):2089-94.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term 80 and over Aged

80 and over Aged Aged Middle Aged Female Male Adult pathology methods drug therapy Disease-Free Survival therapeutic use surgery adverse effects mortality Retrospective Studies Prognosis Survival Rate Cohort Studies Local Neoplasm Recurrence Neoplasm Staging Neoplasms diagnosis Prostatic Neoplasms Young Adult Follow-Up Studies therapy radiotherapy metabolism etiology Ovarian Neoplasms United States Proportional Hazards Models Neoplasm Proteins Fallopian Tube Neoplasms Early Detection of Cancer Double-Blind Method statistics & numerical data Peritoneal Neoplasms Combined Modality Therapy antagonists & inhibitors administration & dosage Neoplasm Invasiveness Kaplan-Meier Estimate epidemiology Survival Analysis Health Insurance Antineoplastic Combined Chemotherapy Protocols Postoperative Complications Head and Neck Neoplasms blood Nephrectomy economics Risk Assessment Biological Tumor Markers Monoclonal Antibodies psychology Prospective Studies Medicare Treatment Outcome analogs & derivatives Risk Factors Rural Population Brachytherapy Breast Neoplasms numerical data ultrasonography B-Cell Lymphoma Gastric Bypass Protein-Tyrosine Kinases Sexual Behavior education statistics & Anus Neoplasms Kidney Function Tests Propensity Score Biological Markers skin neoplasm Radiation Injuries Angiogenesis Inhibitors Educational Status Immunoenzyme Techniques Urothelial carcinoma Skin Neoplasms Vascular Endothelial Growth Factor A Age Factors Community Hospitals Patient Acceptance of Health Care Questionnaires Chemotherapy head and neck cancer Multivariate Analysis Patient-Centered Care Transitional Cell Carcinoma Glomerular Filtration Rate Superoxide Dismutase IGF Type 1 Receptor Weight Loss Merkel Cell Carcinoma Attitudes Health Knowledge-Practice SEER Program Physician's Role Health Services Accessibility use Oxidative Stress Magnetic Resonance Imaging immune function Taxoids Gastrointestinal Diseases Prostatectomy Propionates Length of Stay Pain Counseling Preoperative Care High-Intensity Focused Ultrasound Ablation Registries Survivors Randomized Controlled Trials as Topic Palliative Care Hemangiosarcoma Liver genetics Double-Balloon Enteroscopy Utilization Review biosynthesis Renal-function changes Viral DNA drug effects Psychological Adaptation Physician-Patient Relations Merkel cell carcinoma physiopathology Neoplastic Gene Expression Regulation TOR Serine-Threonine Kinases Immunologic Tests Phase III Clinical Trials as Topic Occult Blood Nutritional Status Pancreas Papillomavirus Infections Reoperation Kidney Neoplasms Deglutition Disorders Hepatectomy baseline weight loss Sulfones Survival Case-Control Studies brachytherapy Marriage
Last updated on Wednesday, March 04, 2015